Think of Adlyxine and Ozempic as Similar to Victoza and Other GLP-1 Agonists

Adlyxine (ad-LIKS-een, lixisenatide) and Ozempic (oh-ZEM-pik, semaglutide) will be the latest "GLP-1 agonists" for type 2 diabetes.

Think of these new meds as similar to Victoza and Trulicity.

They're all injections...and cost at least $120/month.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote